Personalized Feedback for Smoking and Anxiety Sensitivity: A Randomized Controlled Trial

Area of Science:

• Public Health
• Behavioral Science
• Addiction Medicine

Background:

• Cigarette smoking remains a leading global cause of preventable death and disability.
• High relapse rates (over 95% within six months) highlight the need for novel smoking cessation interventions.
• Anxiety sensitivity (AS) is a significant risk factor for continued smoking and relapse.

Purpose of the Study:

• To develop and evaluate a novel, computer-delivered smoking cessation treatment.
• To target anxiety sensitivity (AS) as a key factor in smoking maintenance and relapse.
• To assess the feasibility, acceptability, and initial efficacy of the intervention.

Main Methods:

• A randomized controlled trial was conducted with 95 adult daily smokers.
• An integrated, brief, computer-delivered intervention combining smoking cessation and AS management was tested.
• Participants received either a personalized feedback intervention (PFI) or a smoking information control, assessed at baseline, 2-week, and 4-week follow-ups.

Main Results:

• Both the PFI and control interventions were positively evaluated by participants.
• Quit attempts were reported by 44.2% by the 2-week follow-up and 49.5% by the 4-week follow-up.
• The personalized feedback intervention group showed a higher percentage of quit attempts at 4-week follow-up (57.1%) compared to the control group (41.3%).

Conclusions:

• The single-session, computer-delivered AS/smoking personalized feedback intervention is feasible and acceptable.
• Preliminary data suggest initial efficacy for the developed intervention in promoting smoking quit attempts.
• Further research is warranted to confirm the long-term effectiveness of this approach.